Therefore, based on our pharmacovigilance analyses and on the supporting literature, we raise the hypothesis of 5HT1A agonism as a plausibly pivotal mechanism of the disinhibition proper of TGA-related ICDs, and 5-HT1A antagonism as a promising approach for therapeutic intervention. Here, HTR1A is linked to transposition of the great arteries.